España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

virbac españa, s.a. - virus panleucopenia felina vivo atenuado, cepa lr-72, virus rinotraqueitis infecciosa felina (herpesvirus),vivo atenuado,cepa f2, calicivirus felino vivo atenuado, cepa f9, virus rabia, inactivado, cepa vp12 - liofilizado y disolvente para suspensiÓn inyectable - excipientes: acido 1-glutamico, fosfato dipotasico, fosfato dihidrogeno potasico, lactosa, gelatina, potasio, hidroxido de, solucion tamponada isotonica, cloruro de sodio, fosfato dihidrogeno potasico, fosfato disodico anhidro, hidroxido de aluminio gel, sacarosa, fosfato dipotasico, fosfato dihidrogeno potasico, triptona, solucion tamponada isotonica, cloruro de sodio, fosfato dihidrogeno potasico, fosfato disodico anhidro, agua para preparaciones inyectables - virus vivo de la rinotraqueitis felina + calicivirus felino vivo + virus inactivado de la panleucopenia felina / parvovirus + virus inactivado de la rabia - gatos

Unión Europea - español - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunologicals para felidae, - gatos - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. se han demostrado los inicios de inmunidad una semana después del ciclo de vacunación primaria para componentes de rinotraqueitis, calicivirus, chlamydophila felis y panleucopenia. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Unión Europea - español - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - immunologicals para felidae, - gatos - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs. onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.

Unión Europea - español - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals para felidae, - gatos - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Unión Europea - español - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologicals para felidae, - gatos - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Unión Europea - español - EMA (European Medicines Agency)

merial - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain) - immunologicals para felidae, - gatos - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs and excretion;against chlamydophila felis infection to reduce clinical signs. los inicios de inmunidad se han demostrado 1 semana después del ciclo de vacunación primaria para componentes de rinotraqueitis, calicivirus y chlamydophila felis.. la duración de la inmunidad es de 1 año después de la última (re) vacunación.

Unión Europea - español - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - immunologicals para felidae, - gatos - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs. onsets of immunity isone week after primary vaccination course. the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

virbac s.a. - antigeno p45 del virus de la leucemia felina (felv), calicivirus felino vivo atenuado, cepa f9, virus panleucopenia felina vivo atenuado, cepa lr-72, virus rinotraqueitis infecciosa felina (herpesvirus),vivo atenuado,cepa f2 - liofilizado y disolvente para suspensiÓn inyectable - excipientes: acido 1-glutamico, hidrogenofosfato de disodio anhidro, gelatina, hidrogenofosfato dipotasico, potasio, hidroxido de, cloruro de sodio, fosfato potasico monobasico, saponina, hidroxido de aluminio gel, lactosa monohidrato, fosfato dihidrogeno potasico - virus vivo de la rinotraqueitis felina + calicivirus felino vivo + virus inactivado de la panleucopenia felina / parvovirus + virus de la leucemia felina inactivado - gatos

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

virbac s.a. - antigeno p45 del virus de la leucemia felina (felv), calicivirus felino vivo atenuado, cepa f9, virus rinotraqueitis infecciosa felina (herpesvirus),vivo atenuado,cepa f2, virus panleucopenia felina vivo atenuado, cepa lr-72 - liofilizado y disolvente para suspensiÓn inyectable - excipientes: hidrogenofosfato dipotasico, saponina, fosfato potasico monobasico, lactosa monohidrato, potasio, hidroxido de, gelatina, fosfato dihidrogeno potasico, cloruro de sodio, hidrogenofosfato de disodio anhidro, acido 1-glutamico, hidroxido de aluminio gel - virus vivo de la rinotraqueitis felina + calicivirus felino vivo + virus inactivado de la panleucopenia felina / parvovirus + virus de la leucemia felina inactivado - gatos

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

vetia animal health, s.a.u - herpesvirus bovino tipo 1 (bhv-1), vivo atenuado, cepa bio-27 - liofilizado y disolvente para suspensiÓn inyectable - herpesvirus bovino tipo 1 (bhv-1), vivo atenuado, cepa bio-27 501187.23 dosis infectiva 50% en cultivo celular - virus de la rinotraqueitis bovina (ibr) - bovino